Literature DB >> 19522734

Long-term treatment with fluoxetine induces desensitization of 5-HT4 receptor-dependent signalling and functionality in rat brain.

Rebeca Vidal1, Elsa M Valdizán, Ricardo Mostany, Angel Pazos, Elena Castro.   

Abstract

The mode of action of antidepressant drugs may be related to mechanisms of monoamines receptor adaptation, including serotonin 5-HT(4) receptor subtypes. Here we investigated the effects of repeated treatment with the selective serotonin reuptake inhibitor fluoxetine for 21 days (5 and 10 mg/kg, p.o., once daily) on the sensitivity of 5-HT(4) receptors by using receptor autoradiography, adenylate cyclase assays and extracellular recording techniques in rat brain. Fluoxetine treatment decreased the density of 5-HT(4) receptor binding in the CA1 field of hippocampus as well as in several areas of the striatum over the doses of 5-10 mg/kg. In a similar way, we found a significant lower response to zacopride-stimulated adenylate cyclase activity in the fluoxetine 10 mg/kg/day treated group. Furthermore, post-synaptic 5-HT(4) receptor activity in hippocampus-measured as the excitatory action of zacopride in the pyramidal cells of CA1 evoked by Schaffer collateral stimulation was attenuated in rats treated with both doses of fluoxetine. Taken together, these results support the concept that a net decrease in the signalization pathway of 5-HT(4) receptors occurs after chronic selective serotonin reuptake inhibitor treatment: this effect may underlie the therapeutic efficacy of these drugs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19522734     DOI: 10.1111/j.1471-4159.2009.06210.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  23 in total

1.  Chronic fluoxetine selectively upregulates dopamine D₁-like receptors in the hippocampus.

Authors:  Katsunori Kobayashi; Eisuke Haneda; Makoto Higuchi; Tetsuya Suhara; Hidenori Suzuki
Journal:  Neuropsychopharmacology       Date:  2012-01-25       Impact factor: 7.853

2.  The 5-HT4 receptor levels in hippocampus correlates inversely with memory test performance in humans.

Authors:  Mette Ewers Haahr; Patrick Fisher; Klaus Holst; Karine Madsen; Christian Gaden Jensen; Lisbeth Marner; Szabols Lehel; William Baaré; Gitte Knudsen; Steen Hasselbalch
Journal:  Hum Brain Mapp       Date:  2012-06-26       Impact factor: 5.038

3.  Reduced signal transduction by 5-HT4 receptors after long-term venlafaxine treatment in rats.

Authors:  R Vidal; E M Valdizan; M T Vilaró; A Pazos; E Castro
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

4.  Mucosal serotonin signaling is altered in chronic constipation but not in opiate-induced constipation.

Authors:  Meagan M Costedio; Matthew D Coates; Elice M Brooks; Lisa M Glass; Eric K Ganguly; Hagen Blaszyk; Allison L Ciolino; Michael J Wood; Doris Strader; Neil H Hyman; Peter L Moses; Gary M Mawe
Journal:  Am J Gastroenterol       Date:  2009-12-15       Impact factor: 10.864

Review 5.  The Prostaglandin Transporter: Eicosanoid Reuptake, Control of Signaling, and Development of High-Affinity Inhibitors as Drug Candidates.

Authors:  Victor L Schuster; Yuling Chi; Run Lu
Journal:  Trans Am Clin Climatol Assoc       Date:  2015

6.  Region-specific regulation of 5-HT1B receptors in the rat brain by chronic venlafaxine treatment.

Authors:  R Vidal; A Diaz; A Pazos; E Castro
Journal:  Psychopharmacology (Berl)       Date:  2013-04-23       Impact factor: 4.530

7.  Donecopride, a Swiss army knife with potential against Alzheimer's disease.

Authors:  Christophe Rochais; Cédric Lecoutey; Katia Hamidouche; Patrizia Giannoni; Florence Gaven; Eleazere Cem; Serge Mignani; Kevin Baranger; Thomas Freret; Joël Bockaert; Santiago Rivera; Michel Boulouard; Patrick Dallemagne; Sylvie Claeysen
Journal:  Br J Pharmacol       Date:  2020-02-11       Impact factor: 8.739

8.  Selective serotonin reuptake inhibitors pathway.

Authors:  Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2009-11       Impact factor: 2.089

9.  BDNF Val66met and 5-HTTLPR polymorphisms predict a human in vivo marker for brain serotonin levels.

Authors:  Patrick M Fisher; Klaus K Holst; Dea Adamsen; Anders Bue Klein; Vibe G Frokjaer; Peter S Jensen; Claus Svarer; Nic Gillings; William F C Baare; Jens D Mikkelsen; Gitte M Knudsen
Journal:  Hum Brain Mapp       Date:  2014-09-13       Impact factor: 5.038

10.  Central 5-HT4 receptor binding as biomarker of serotonergic tonus in humans: a [11C]SB207145 PET study.

Authors:  M E Haahr; P M Fisher; C G Jensen; V G Frokjaer; B Mc Mahon; K Madsen; W F C Baaré; S Lehel; A Norremolle; E A Rabiner; G M Knudsen
Journal:  Mol Psychiatry       Date:  2013-11-05       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.